ES8601181A1 - Procedimiento de preparacion del 4 (2-(2-tenoil)-amino-3,5- dibromofenil)-metil-amino-ciclohexanol - Google Patents

Procedimiento de preparacion del 4 (2-(2-tenoil)-amino-3,5- dibromofenil)-metil-amino-ciclohexanol

Info

Publication number
ES8601181A1
ES8601181A1 ES540041A ES540041A ES8601181A1 ES 8601181 A1 ES8601181 A1 ES 8601181A1 ES 540041 A ES540041 A ES 540041A ES 540041 A ES540041 A ES 540041A ES 8601181 A1 ES8601181 A1 ES 8601181A1
Authority
ES
Spain
Prior art keywords
antibronchopneumopathic
activity
compound
preparation
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES540041A
Other languages
English (en)
Other versions
ES540041A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PULITZER ITALIANA
Original Assignee
PULITZER ITALIANA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PULITZER ITALIANA filed Critical PULITZER ITALIANA
Publication of ES540041A0 publication Critical patent/ES540041A0/es
Publication of ES8601181A1 publication Critical patent/ES8601181A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 4-Y2-(2-TENOIL)-AMINO-35-DIBROMOFENIL)-METIL-AMINOZ-CICLOHEXANOL. CONSISTE EN LA REACCION DE CONDENSACION DEL 4-Y(2-AMINO-35-DIBROMOFENIL)-METIL-AMINOZ-CICLOHEXANOL CON CLORURO DE 2-TENOILO. LA REACCION SE LLEVA A CABO EN UN DISOLVENTE ORGANICO INERTE TAL COMO TOLUENO EN PRESENCIA DE UN AGENTE ACEPTOR DE ACIDO TAL COMO CARBONATO O BICARBONATO ALCALINO O UNA AMINA TERCIARIA A UNA TEMPERATURA COMPRENDIDA ENTRE 10JC Y LA DE REFLUJO DEL DISOLVENTE. ESTE COMPUESTO TIENE APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE AFECCIONES DEL APARATO RESPIRATORIO AGUDAS O CRONICAS.
ES540041A 1984-02-02 1985-02-01 Procedimiento de preparacion del 4 (2-(2-tenoil)-amino-3,5- dibromofenil)-metil-amino-ciclohexanol Expired ES8601181A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8419374A IT1213132B (it) 1984-02-02 1984-02-02 Agente antibroncopneumopatico.

Publications (2)

Publication Number Publication Date
ES540041A0 ES540041A0 (es) 1985-11-01
ES8601181A1 true ES8601181A1 (es) 1985-11-01

Family

ID=11157151

Family Applications (1)

Application Number Title Priority Date Filing Date
ES540041A Expired ES8601181A1 (es) 1984-02-02 1985-02-01 Procedimiento de preparacion del 4 (2-(2-tenoil)-amino-3,5- dibromofenil)-metil-amino-ciclohexanol

Country Status (5)

Country Link
EP (1) EP0150787B1 (es)
AT (1) ATE33835T1 (es)
DE (2) DE150787T1 (es)
ES (1) ES8601181A1 (es)
IT (1) IT1213132B (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248702B (it) * 1990-06-06 1995-01-26 Yason Srl Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche
WO2014037832A2 (en) 2012-09-06 2014-03-13 Mahesh Kandula Compositions and methods for the treatment of epilepsy and neurological diseases
EP2847158A4 (en) 2012-05-07 2015-12-30 Cellix Bio Private Ltd COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS AND NEURODEGENERATIVE DISORDERS
US9399634B2 (en) 2012-05-07 2016-07-26 Cellix Bio Private Limited Compositions and methods for the treatment of depression
CA2872975A1 (en) 2012-05-07 2013-11-14 Cellixbio Private Limited Compositions and methods for the treatment of neurological disorders
US9266823B2 (en) 2012-05-08 2016-02-23 Cellix Bio Private Limited Compositions and methods for the treatment of parkinson's disease
US9522884B2 (en) 2012-05-08 2016-12-20 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic disorders
US9403826B2 (en) 2012-05-08 2016-08-02 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory disorders
WO2013168025A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treatment of blood clotting disorders
US9434704B2 (en) 2012-05-08 2016-09-06 Cellix Bio Private Limited Compositions and methods for the treatment of neurological degenerative disorders
US9499527B2 (en) 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of familial amyloid polyneuropathy
US9233161B2 (en) 2012-05-10 2016-01-12 Cellix Bio Private Limited Compositions and methods for the treatment of neurological conditions
WO2013167997A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of metabolic syndrome
WO2013168000A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of severe pain
WO2013168011A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of chronic pain
US9315461B2 (en) 2012-05-10 2016-04-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurologic diseases
WO2013168015A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of asthma and allergy
WO2013168012A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of respiratory disorders
WO2013168001A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
SG11201407318UA (en) 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of metabolic syndrome
US9339484B2 (en) 2012-05-10 2016-05-17 Cellix Bio Private Limited Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
WO2013168033A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for treatment of neurologic diseases
US9346742B2 (en) 2012-05-10 2016-05-24 Cellix Bio Private Limited Compositions and methods for the treatment of fibromyalgia pain
JP2015518855A (ja) 2012-05-23 2015-07-06 セリックスビオ プライヴェート リミテッド 粘膜炎の治療のための組成物および方法
WO2013175347A2 (en) * 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of respiratory disorders
JP2015518854A (ja) 2012-05-23 2015-07-06 セリックスビオ プライヴェート リミテッド 多発性硬化症の治療のための組成物および方法
JP6202287B2 (ja) 2012-05-23 2017-09-27 セリックスビオ プライヴェート リミテッド 炎症性腸疾患の治療のための組成物及び方法
US9492409B2 (en) 2012-05-23 2016-11-15 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
US9434729B2 (en) 2012-05-23 2016-09-06 Cellix Bio Private Limited Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
WO2014020480A2 (en) 2012-08-03 2014-02-06 Mahesh Kandula Compositions and methods for the treatment migraine and neurologic diseases
US9624168B2 (en) 2012-09-06 2017-04-18 Cellix Bio Private Limited Compositions and methods for the treatment inflammation and lipid disorders
SG11201407325YA (en) 2012-09-08 2014-12-30 Cellix Bio Private Ltd Compositions and methods for treatment of inflammation and lipid disorders
US9333187B1 (en) 2013-05-15 2016-05-10 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
EP3004049B1 (en) 2013-06-04 2018-09-05 Cellixbio Private Limited Compositions and methods for the treatment of diabetes and pre-diabetes
US9096537B1 (en) 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
EP3240779B1 (en) 2014-09-26 2020-10-28 Cellixbio Private Limited Compositions and methods for the treatment of epilepsy and neurological disorders
EP3201168B1 (en) 2014-09-29 2020-03-18 Cellix Bio Private Limited Compounds and compositions for the treatment of multiple sclerosis
CA2965449C (en) 2014-10-27 2020-11-10 Cellix Bio Private Limited Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
US9173877B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
US10208014B2 (en) 2014-11-05 2019-02-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurological disorders
US9175008B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Prodrugs of anti-platelet agents
US9150557B1 (en) 2014-11-05 2015-10-06 Cellix Bio Private Limited Compositions and methods for the treatment of hyperglycemia
US9321716B1 (en) 2014-11-05 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9290486B1 (en) 2014-11-05 2016-03-22 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy
US9284287B1 (en) 2014-11-05 2016-03-15 Cellix Bio Private Limited Compositions and methods for the suppression of carbonic anhydrase activity
US9932294B2 (en) 2014-12-01 2018-04-03 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en) 2014-12-17 2015-12-08 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases
EP3242869B1 (en) 2015-01-06 2021-10-27 Cellixbio Private Limited Compositions and methods for the treatment of inflammation and pain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1593579B1 (de) * 1966-05-10 1972-02-03 Thomae Gmbh Dr K Hydroxy-cyclohexylamine,deren physiologisch vertraeglichen Saeureadditionssalze und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
IT1213132B (it) 1989-12-14
EP0150787B1 (en) 1988-04-27
EP0150787A3 (en) 1985-08-21
ES540041A0 (es) 1985-11-01
DE150787T1 (de) 1986-01-02
DE3562374D1 (en) 1988-06-01
IT8419374A0 (it) 1984-02-02
EP0150787A2 (en) 1985-08-07
ATE33835T1 (de) 1988-05-15

Similar Documents

Publication Publication Date Title
ES8601181A1 (es) Procedimiento de preparacion del 4 (2-(2-tenoil)-amino-3,5- dibromofenil)-metil-amino-ciclohexanol
DE69022453D1 (de) N-(3-Hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran oder dihydrobenzodioxin)-carboxamid-Derivate.
EP0363212A3 (en) Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
NO851933L (no) Fremgangsmaate ved fremstilling av terapeutisk aktivt (5)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
DK74691D0 (da) 4(4-(substitueret phenyl)-1-piperazinyl)phenoler og fremgangsmaade til fremstilling deraf
EP0353955A3 (en) Novel compounds
DE3674448D1 (de) N-((4-piperidinyl)-alkyl)-substituierte bicyclische kondensierte oxazol- und thiazolamine.
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
GB1453703A (en) Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them
DE3164741D1 (en) 2-(4-(diphenylmethylene)-1-piperidinyl)-acetic acids and their amides, their preparation and pharmaceutical preparations containing them
KR960009422B1 (en) 4-(ardylamino)piperidinebutanamide derivatives
GB1497729A (en) Benzenesulphonyl ureas and process for their manufacture
GB1450801A (en) Pyridinecarboxamide sulphonylurea hypoglycemic agents
HU903092D0 (en) Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
DE3668888D1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
ATE128464T1 (de) Carboximidamid-derivate.
SE8204670D0 (sv) Ny forening med antiulcerogen aktivitet, forfarande for dess framstellning och farmaceutisk beredning innehallande densamma
JPS5753481A (en) 4-hydrouracil-piperidines
JPS5740408A (en) Hypoglycemic
DK158513C (da) N-(substitueret phenyl)-n'-pyridinylurinstoffer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
IL61234A (en) Guanidino thiazolyl alkylamino(alkylthioalkylamino)nitrotetrahydropyridines,process for preparing them and pharmaceutical compositions containing them
JPS6485966A (en) Benzoylurea-based compound, harmful animal controller containing said compound and production thereof
JPS57169463A (en) Preparation of carbostyril derivative
KR860000284A (ko) 디하이드로피리딘의 제조방법